Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Asset Writedowns and Impairment (2020 - 2025)

NeuroPace (NPCE) has 6 years of Asset Writedowns and Impairment data on record, last reported at $60000.0 in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 9.09% year-over-year to $60000.0; the TTM value through Dec 2025 reached $200000.0, down 20.32%, while the annual FY2025 figure was $200000.0, 20.32% down from the prior year.
  • Asset Writedowns and Impairment reached $60000.0 in Q4 2025 per NPCE's latest filing, up from $47000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $138000.0 in Q2 2021 and bottomed at $23000.0 in Q3 2021.
  • Average Asset Writedowns and Impairment over 5 years is $56600.0, with a median of $48000.0 recorded in 2024.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 92.2% in 2021, then soared 241.67% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $57000.0 in 2021, then tumbled by 31.58% to $39000.0 in 2022, then soared by 64.1% to $64000.0 in 2023, then fell by 14.06% to $55000.0 in 2024, then rose by 9.09% to $60000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $60000.0 in Q4 2025, $47000.0 in Q3 2025, and $49000.0 in Q2 2025.